DEA deschedules CBD Antiepileptic Drug

CBD-based drug will be freely prescribed by doctors.
June 27, 2018

This post is also available in: Español

CBD-based drug will be freely prescribed by doctors

The Drug Enforcement Administration (DEA) announced that a cannabidiol-based drug (CBD) will no be a schedule I drug of the Controlled Substances Act at the federal level.

This is the second step in the line of requirements to make the drug Epiodiolex, an oral solution for patients with severe seizures, more accessible to families throughout the United States.

In November 2018, the Food and Drug Administration (FDA) approved this drug for distribution in the US.

“This notification from DEA fully establishes that EPIDIOLEX, the only CBD medicine approved by FDA, is no longer a controlled substance under the federal Controlled Substances Act,” said Justin Gover, GW’s Chief Executive Officer. 

Previously, cannabis was part of the List I in the Controlled Substances Act. This list is compound by this drugs that supposed to have no medical effect.

From now on, cannabis or this CBD drug based, is in List V, the list for safe drugs for medical use.

Patients suffering from diseases known as Lennox-Gastaut or Dravet Syndrome will now be able to access a prescription more easily.

"Epidiolex is the first pharmaceutical prescription formulated with highly purified cannabis derivatives (CBD) and the first in the new category of antiepileptic drugs".

High price

Through its subsidiary, the company will begin with an implementation of distribution chains across different states with their different permissions and legal processes. This process could take months or years depending on the controls in each state.

Now, the biggest problem is the high price of this drug.  According to analysis in 2018, the costs can amount to $32,500 per year.

This post is also available in: Español

Escrito por: Editores MCN
Publicado en la revista 
SíGUENOS EN INSTAGRAM COMO @MCNGLOBAL
This error message is only visible to WordPress admins

Error: No connected account.

Please go to the Instagram Feed settings page to connect an account.

Lo más reciente en MCN

También te puede interesar

October 21, 2020
Mario Cerdas: "In the accusatory piece I am not accused of trafficking cannabis anywhere"

Lawyer Cerdas is not accused of selling or distributing cannabis

Ver Artículo
October 19, 2020
Director of the OIJ on cannabis: "It will be transcendent that the cultivation action is preordered to trafficking to be a crime"

A book written in 2009, the current director of the OIJ, Walter Espinoza proposes that cannabis cultivation is not necessarily a crime

Ver Artículo
October 16, 2020
Procomer study shows potential for CBD and hemp products in Costa Rica

Industrial hemp has been chosen for its great export capacity.

Ver Artículo
October 15, 2020
Mario Cerdas, the other side of the story. Exclusive interview from prison. 2nd Part.

The activist and lawyer Mario Cerdas talk about the upcoming trial against the state.

Ver Artículo
Copyright Zegreenlab S.A. Todos los derechos reservados © 2020. Hecho en Costa Rica.
Diseño & Desarrollo por Dbugger Studio
magnifiercrossmenucross-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram